Murine models of idiopathic inflammatory myopathies

Naoko Okiyama,Risa Konishi,Yuki Ishimura
DOI: https://doi.org/10.1111/1346-8138.17142
IF: 3.468
2024-02-07
The Journal of Dermatology
Abstract:Idiopathic inflammatory myopathies (IIMs) are divided into polymyositis and dermatomyositis (DM) with specific cutaneous manifestation. Several myositis‐specific autoantibodies (MSAs) have been identified in IIMs and were found to be associated with distinct clinical features, including anti‐synthetase syndrome (ASyS) and immune‐mediated necrotizing myopathy (IMNM). Moreover, MSA‐related clinical features have been identified even within DM. Although MSAs are valuable for the diagnosis of IIMs, the pathogenic roles of these antibodies remain unknown. To investigate the pathogenesis of IIMs, classical murine models of autoimmune myositis, experimental autoimmune myositis, and C protein‐induced myositis have been established by immunization with muscle‐specific antigens, myosin, and myosin‐binding skeletal C protein, respectively. To according to MSA‐related autoimmunity, a murine model of ASyS was generated by immunization with a murine recombinant histidyl‐transfer RNA (tRNA) synthetase, Jo‐1, in which muscle and lung inflammation are induced depending on acquired immunity. Furthermore, it was found that the transfer of human Immunoglobulin G (IgGs) from patients with IMNM, comprising anti‐signal recognition particles and anti‐3‐hydroxy‐3‐methylglutaryl coenzyme A reductase antibodies, induced complement‐mediated myositis in recipient mice. We found that CD8+ T cell‐mediated myositis can be established depending on autoimmunity against transcriptional intermediary factor 1γ (TIF1γ), an autoantigen for MSAs induced by recombinant human TIF1γ immunization. These new murine models reflecting MSA‐associated IIMs will reveal the immunological mechanisms underlying IIMs.
dermatology
What problem does this paper attempt to address?